James L. Rubenstein, MD, PhD

Rare diseases treated or studied

Based on trial PI assignments and publication topics.

• Interdigitating dendritic cell sarcoma→
• Nodal marginal zone B-cell lymphoma→
• Acute lymphoblastic leukemia→
• Lymphoproliferative disease associated with primary immune disease→
• Epstein-Barr Virus-related tumor→
• MALT lymphoma→
• Chronic graft versus host disease→
• B-cell chronic lymphocytic leukemia→
• Hodgkin lymphoma→
• Mantle cell lymphoma→
• Primary central nervous system lymphoma→
• Plasma cell tumor→
• Follicular lymphoma→
• Diffuse large B-cell lymphoma→
• B-cell non-Hodgkin lymphoma→
• Plasma cell leukemia→
• Splenic marginal zone lymphoma→
• Waldenström macroglobulinemia→
• Precursor B-cell acute lymphoblastic leukemia→
• Burkitt lymphoma→
• Plasmablastic lymphoma→
• Tumor of meninges→
• Marginal zone lymphoma→
• Lymphoma→

Clinical trials (2)

• NCT00416923
• NCT00416819

Verify independently

• ClinicalTrials.gov PI search for James L. Rubenstein, MD, PhD

Other specialists for Interdigitating dendritic cell sarcoma

Peers ranked by clinical-trial PI role, publications, and verification quality.

• David Maloney
  Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
• Ajay Gopal
  Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
  WA
• Paolo Caimi, MD, M.D
  Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center
  OH
• Thomas G. Martin, MD
  University of California, San Francisco
• Peter Johnson, MD
  University Hospital Southampton NHS Foundation Trust
• Susan K. Parsons, MD, MRP
  Tufts Medical Center Cancer Center
• Paul Martin
  Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
• Nirali N Shah, M.D.
  National Cancer Institute (NCI)

See all specialists for Interdigitating dendritic cell sarcoma →